Remove Acquisition Remove Offshore Remove Software Review Remove Technical Review
article thumbnail

Opinion: It’s a startup world

NZ Entrepreneur

If we want to maintain and support sustainable economic growth while meeting the broader needs of society, we will need an economy underpinned by innovation and new technologies. scale – this may include the need to go offshore. Take part in startup investment due diligence. Suse Reynolds, Angel Association New Zealand.

article thumbnail

Can A Startup Do OffShore Development? Part 2

prosperati.com

Prosperati HOME BLOG ABOUT CONTACT Blog Can A Startup Do OffShore Development? Part 2 Posted 07.15.2009 in Blog In my previous article ( Can a Startup Do OffShore Development? Part 1 ), I talked about alignment of interest and trust as being the two most critical aspect when starting a new offshore development team.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

From Nothing To Something. How To Get There.

techcrunch.com

Tech Gadgets Mobile Enterprise GreenTech CrunchBase TechCrunch TV Disrupt SF More TechCrunch TV Beta Invites Crunchies Elevator Pitches Gillmor Gang Podcasts TechCrunch Europe TechCrunch Trends TechCrunch France TechCrunch Japan Whats Hot: Android Apple Facebook Google Microsoft Twitter Yahoo Zynga Subscribe: From Nothing To Something.

article thumbnail

Expenses You Don't Think of When Starting a Business

Software By Rob

I ruffled a few feathers with my recent post The Software Product Myth. The unrest surrounded my statement that making $2500/month from your software product wouldn’t allow you to quit your day job. As I said in The Five Minute Guide to Becoming a Freelance Software Developer , an accountant is not an optional expense.

article thumbnail

Reinventing Life Science Startups–Therapeutics and Diagnostics

Steve Blank

has gone offshore primarily due to the toughened regulatory environment. For exits, acquisitions are the rule and IPOs the exception. Biologics can be made from human, animal, or microorganisms – or produced by recombinant DNA technology. Pharma companies are staggering under the costs.